Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05453513 · ClinicalTrials.gov registry record · NA

The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV

A NA study of Depression and HIV, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
280
Enrollment target
1
Study location

NCT05453513 is a NA study of Depression and HIV that is actively recruiting participants, run by University of Miami. The registered enrollment target is 280 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05453513, a NA study of Depression and HIV, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
1
Study location

Study Summary

To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study team proposes a tightly integrative study to test the overall hypothesis that cannabis use and depression in young PLWH have an additive effect, inducing both reward deficits and pain hypersensitivity, and that this pattern will predict worse outcomes at 1 year follow-up.

Interventions

  • BEHAVIORAL MRI Study

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2022-04-01
Est. Completion 2027-07-30
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05453513

The ClinicalTrials.gov registry entry for NCT05453513 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which MRI Study is the first listed.

NCT05453513 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05453513 about?

NCT05453513 is a clinical study titled "The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV". To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study team proposes a tightl...

What is the current status of trial NCT05453513?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2022-04-01. Estimated completion is 2027-07-30.

What conditions does trial NCT05453513 study?

This clinical trial studies the following conditions: Depression, HIV, Cannabis Use Disorder.

What interventions are being tested in trial NCT05453513?

The interventions under investigation include: MRI Study (BEHAVIORAL).

Who is sponsoring clinical trial NCT05453513?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05453513 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.